BioCentriq Names New CEO
19 Sep 2024 //
CONTRACT PHARMA
BioCentriq Appoints Syed T. Husain as Chief Executive Officer
19 Sep 2024 //
PR NEWSWIRE
Autolomous and BioCentriq Partner to Transform Operations
03 Apr 2024 //
CONTRACT PHARMA
BioCentriq And Pluristyx Strengthen Partnership For IPSC-NK Cell Therapies
07 Mar 2024 //
PRESS RELEASE
BioCentriq Presents CAR-T Data From Terumo`s Quantum Flex System
29 Feb 2024 //
PRESS RELEASE
GC Cell And BioCentriq Sign Agreement For US Entry Of Immuncell-LC Inj
26 Feb 2024 //
PRESS RELEASE
Premier Research And BioCentriq Partner To Accelerate Cell Therapy Development
08 Jan 2024 //
PRESS RELEASE
Cytiva, BioCentriq Awarded NIIMBL Funding to Advance Gene Therapies
27 Jun 2023 //
CONTRACT PHARMA
BioCentriq Completes Tech Transfer From Avenge Bio
18 Jan 2023 //
CONTRACT PHARMA
Jackie Veivia-Panter Joins BioCentriq as Chief Quality and Compliance Officer
06 Dec 2022 //
PRNEWSWIRE
BioCentriq Cuts the Ribbon to Open GMP Manufacturing Site
01 Nov 2022 //
PRNEWSWIRE
GC to Acquire US CDMO BioCentriq
21 Apr 2022 //
CONTRACTPHARMA
GC Signs Definitive Agreement to Acquire US CDMO BioCentriq
19 Apr 2022 //
BUSINESSWIRE
Tevogen Completes Tech Transfer to CDMO BioCentriq
16 Sep 2021 //
CONTRACTPHARMA
CaroGen, BioCentriq Enter Clinical Manufacturing Pact
22 Jun 2021 //
CONTRACTPHARMA
CaroGen Partners with BioCentriq for Clinical Production of CARG-201
22 Jun 2021 //
PRWEB